A prospective examination of disease management program use by complex cardiac outpatients

Shannon Gravely1, Robert D Reid, Paul Oh

  • 1York University, Toronto, Ontario, Canada.

Insights

Many cardiovascular disease (CVD) patients do not use disease management programs (DMPs). Younger age, marriage, and higher personal control were linked to DMP use, while diabetes and stroke increased multiple DMP utilization.

Area of Science:

  • Cardiovascular Medicine
  • Health Services Research
  • Chronic Disease Management

Background:

  • Disease management programs (DMPs) improve outcomes for cardiovascular disease (CVD) patients.
  • Cardiac rehabilitation (CR) use is known, but other DMP utilization is less understood.
  • This study investigates DMP use patterns and influencing factors in CVD outpatients.

Purpose of the Study:

  • To determine the extent of DMP utilization among cardiovascular disease outpatients.
  • To identify patient characteristics and factors associated with DMP use.
  • To understand the patterns of utilizing single versus multiple DMPs.

Main Methods:

  • Secondary analysis of a prospective cohort study involving 2635 CVD inpatients from 11 Ontario hospitals.
  • Initial in-hospital survey assessed factors influencing DMP utilization.
  • A follow-up mailed survey one year later assessed DMP utilization in 1803 participants.

Main Results:

  • 59.5% of participants (1073/1803) reported using at least one DMP.
  • Cardiac rehabilitation was the most common DMP (52.7%).
  • Younger age, marriage, myocardial infarction diagnosis, fewer percutaneous coronary interventions, and higher perceived personal control were associated with DMP use. Diabetes and comorbid stroke increased the likelihood of using multiple DMPs.

Conclusions:

  • Approximately 40% of cardiovascular disease outpatients do not utilize available disease management programs.
  • An integrated approach to vascular disease management is recommended to improve patient outcomes.
  • Further research into barriers and facilitators of DMP access for CVD patients is warranted.
Abstract

Related Concept Videos

Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...